Back to Search
Start Over
piR-26441 inhibits mitochondrial oxidative phosphorylation and tumorigenesis in ovarian cancer through m6A modification by interacting with YTHDC1.
- Source :
-
Cell death & disease [Cell Death Dis] 2025 Jan 18; Vol. 16 (1), pp. 25. Date of Electronic Publication: 2025 Jan 18. - Publication Year :
- 2025
-
Abstract
- Ovarian cancer (OC) is a heterogeneous cancer. In contrast to other tumor cells, which rely primarily on aerobic glycolysis (Warburg effect) as their energy source, oxidative phosphorylation (OXPHOS) is also one of its major metabolic modes. Piwi-interacting RNAs (piRNAs) play a regulatory function in various biological processes in tumor cells. However, the role and mechanisms of piRNAs in OC and mitochondrial OXPHOS remain to be elucidated. Here, we found that piR-26441 was aberrantly downregulated in OC, and its overexpression suppressed the malignant features of OC cells and tumor growth in a xenograft model. Moreover, overexpression of piR-26441 significantly reduced mitochondrial OXPHOS levels in OC cells. Furthermore, piR-26441 directly binds to and upregulates the expression of YTHDC1 in OC cells. piR-26441 also increased m6A levels, thereby interacting with YTHDC1 to destabilize the mRNA of TSFM. The resultant TSFM loss reduced mitochondrial complex I activity and mitochondrial OXPHOS, leading to mitochondrial dysfunction in OC cells, increased reactive oxygen species levels, and thus, DNA damage and apoptosis in OC cells, thereby inhibiting OC progression. Additionally, ago-piR-26441 suppressed tumor growth and mitochondrial metabolism in the patient-derived organoid model. Altogether, piR-26441 could inhibit OC cell growth via the YTHDC1/TSFM signaling axis, underscoring its significant importance in the context of OC, as well as offering potential as a therapeutic target.<br />Competing Interests: Competing interests: The authors declare no competing interests. Ethics approval: The Ethics Committee of the Third Affiliated Hospital of Guangzhou Medical University (No: 2021-055) approved the use of human tissue in this study. All animal experiments were approved and conducted by Guangdong Medical Laboratory Animal Center (Approval No. B202208-8). We conformed with the Helsinki Declaration of 1975 (as revised in 2008) concerning Human and Animal Rights.<br /> (© 2025. The Author(s).)
- Subjects :
- Humans
Female
Animals
Cell Line, Tumor
Mice
RNA Splicing Factors metabolism
RNA Splicing Factors genetics
RNA, Small Interfering metabolism
Adenosine metabolism
Adenosine analogs & derivatives
Gene Expression Regulation, Neoplastic
Mice, Inbred BALB C
Apoptosis
Cell Proliferation
Reactive Oxygen Species metabolism
Nerve Tissue Proteins
Oxidative Phosphorylation
Mitochondria metabolism
Ovarian Neoplasms metabolism
Ovarian Neoplasms pathology
Ovarian Neoplasms genetics
Carcinogenesis metabolism
Carcinogenesis genetics
Mice, Nude
Subjects
Details
- Language :
- English
- ISSN :
- 2041-4889
- Volume :
- 16
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Cell death & disease
- Publication Type :
- Academic Journal
- Accession number :
- 39827178
- Full Text :
- https://doi.org/10.1038/s41419-025-07340-6